1 / 7

Microbiology Testing/Clinical Microbiology Market Worth 5.77 Billion USD by 2021

The Global Clinical Microbiology Market Is Projected to reach USD 5.77 Billion by 2021 From USD 3.35 Billion in 2016, at a CAGR of 11.5%, during 2016 to 2021.

jessicakellymnm1234
Download Presentation

Microbiology Testing/Clinical Microbiology Market Worth 5.77 Billion USD by 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Microbiology Testing/Clinical Microbiology Market Worth 5.77 Billion USD by 2021 www.MarketsandMarkets.com

  2. According to a new market research report "Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021", published by MarketsandMarkets, The Global Clinical Microbiology Market Is Projected to reach USD 5.77 Billion by 2021 From USD 3.35 Billion in 2016, at a CAGR of 11.5%, during 2016 to 2021. www.MarketsandMarkets.com

  3. Browse 74 market data tables with 62 figures spread through 176 pages and in-depth TOC on "Microbiology Testing / Clinical Microbiology Market“ http://www.marketsandmarkets.com/Market-Reports/microbiology-testing-market-219135367.html Early buyers will receive 10% customization on this report. Technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science researches are the key market drivers for the clinical microbiology industry. Furthermore, improving healthcare infrastructure across the emerging markets and growing market demand for advanced molecular diagnostic products provide opportunities for players in the Clinical Microbiology Market.

  4. On the basis of product, the Clinical Microbiology Market is categorized into instruments [laboratory instruments (incubators, gram strainers, bacterial colony counters, autoclave sterilizers, microbial air samplers, anaerobic culture systems, petridish fillers, blood culture systems, microbial culture systems, and other laboratory instruments) and microbiology analyzers (molecular diagnostic instruments, microscopes, and mass spectrometers)] and reagents (pathogen specific kits and general reagents). The instruments segment is expected to account for the larger share of the global Clinical Microbiology Market in 2016. However, reagents segment is projected to grow faster than the instruments segment, growing at a double-digit CAGR during 2016-2021. Get Report PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=219135367 www.MarketsandMarkets.com

  5. Growth in the reagents segment is mainly driven by growing trend of reagent rental agreements (along with instrument sales) by prominent reagent manufacturers, rising private-public funding for researches on specific infectious diseases, increasing market availability of pathogen-specific kits across the globe, and growing demand for specific clinical microbiology reagents during epidemic outbreaks. Leading players in the Clinical Microbiology Market include bioMerieux S.A. (France), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.). www.MarketsandMarkets.com

  6. Browse Related Reports: Molecular Diagnostics Market - by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020. http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html In Vitro Diagnostics (IVD) Market - by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020. http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html www.MarketsandMarkets.com

  7. About Report Publisher: • MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. • Annual Market Research Reports Subscription -http://www.marketsandmarkets.com/Subscription.html • Contact: • Mr. Rohan • Markets and Markets • UNIT no 802, Tower no. 7, SEZ • Magarpatta city, Hadapsar • Pune, Maharashtra 411013, India • 1-888-600-6441 www.MarketsandMarkets.com

More Related